Products | Amoli Organics Pvt. Ltd

Commercial Products

Product	Therapeutic Use	Regulatory Status (USDMF / CEP)
Aceclofenac BP / EP	Anti-inflammatory	CEP
Apixaban	Anti-coagulant	USDMF, EDMF
Atorvastatin Calcium Crystalline BP/ EP /USP	Anti-hyperlipidemic	USDMF, CEP
Carbamazepine BP / EP / JP /USP	Anti-Convulsant	USDMF, CEP
Celecoxib BP / EP /USP	Anti-inflammatory	USDMF, CEP
Chlorpromazine EP/USP	Antipsychotic	USDMF (Q4 2021), EDMF
Chlorthalidone EP /USP	Diuretic	USDMF, EDMF
Clotrimazole BP / EP /USP	Anti-fungal	USDMF, CEP
Deferasirox	Iron chelating agent	USDMF, CEP filed
Desvenlafaxine Succinate	Anti depressant	USDMF
Diclofenac Deanol	Anti-inflammatory	EDMF
Diclofenac Diethylamine BP	Anti-inflammatory	USDMF, EDMF
Diclofenac Epolamine	Anti-inflammatory	USDMF, EDMF
Diclofenac Free Acid	Anti-inflammatory	USDMF, EDMF
Diclofenac Potassium BP / EP /USP	Anti-inflammatory	USDMF, CEP
Diclofenac Resinate	Anti-inflammatory	EDMF
Diclofenac Salts
Diclofenac Sodium (BromineFree) BP / EP / JP / USP	Anti-inflammatory	USDMF, CEP
Dihydralazine Sulphate BP /EP	Anti-hypertensive	CEP
Dimethyl Fumarate	Multiple Sclerosis	USDMF, EDMF
Eslicarbazepine	Anti Convulsant	USDMF, EDMF
Hydrochlorothiazide BP / EP / USP	Diuretic	USDMF, CEP
Levetiracetam EP / USP	Anti-Convulsant	USDMF, CEP
Mesalamine / Mesalazine	Anti-inflammatory (IBD)	USDMF, CEP
Mirabegron	Overactive bladder	USDMF, EDMF
Olmesartan Medoxomil EP / USP	Anti-hypertensive	USDMF, CEP
Oxcarbazepine EP / USP	Anti-convulsant	USDMF, CEP
Pirfenidone	Fibrosis	USDMF, CEP
Ranolazine	Anti-anginal	EDMF, USDMF
Rivaroxaban	Anticoagulant	USDMF, CEP filed
Rosuvastatin EP	Anti-hyperlipidemic	USDMF, CEP
Sertraline HCL BP / EP / USP	Anti-depressant	USDMF, CEP
Sildenafil Citrate EP/ USP	Erectile dysfunction	USDMF, CEP
Sitagliptin Phosphate Anhydrous	Diabetes	USDMF
Solifenacin Succinate	Overactive bladder	USDMF, CEP
Succinylcholine / Suxamethonium Chloride	Muscle Relaxant	USDMF, EDMF
Tadalafil EP/ USP	Erectile dysfunction	USDMF, CEP
Ticagrelor	Antiplatelet	DMF
Varenicline Tartarate		USDMF, EDMF
Venlafaxine HCL BP / EP / USP	Anti-depressant	USDMF, CEP

Pipeline Products

Product	Therapeutic Use	Regulatory Status (USDMF / CEP)
Apremilast	Psoriasis	Q2 2023
Dapagliflozin Amorphous	Diabetes	Q2 2023
Dapagliflozin Propanediol Monohydrate	Diabetes	Q2 2023
Edoxaban	Anti-coagulant	Q2 2023
Elagolix	Endometriosis	Under development
Empagliflozin	Diabetes	Q3 2023
Linagliptin	Diabetes	Q2 2023
Sacubitril/Valsartan	Heart failure	Q4 2022
Sitagliptin Phosphate Monohydrate	Diabetes	Q2 2023
Vortioxetine Hydrobromide	Anti-depressant	Q2 2023

Disclaimer: Products covered by valid patents in any country are not offered or supplied for commercial use to these countries.
The patent position of the product should be verified by the buyer.
Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).
The Product information mentioned here is not intended to provide complete medical information.
Product information outlined herein should not be construed as a promotion or solicitation for any Product or service or for the use of any Product or service that is not authorized by the laws and regulations of India.

CDMO SERVICES

. . . . . . . . . . .

Amoli aims to be reliable partner for contract development and manufacturing services (CDMO) by leveraging its expertise in the field of process chemistry and commercial API manufacturing. With world class manufacturing facilities approved by a host of regulatory agencies and the capability to handle complex reactions from lab scale all the way to plant scale, Amoli can offer best-in-class solutions for your outsourcing needs.